Title and Abstract
Provide a concise title and abstract summarizing objectives, hypothesis, study design, sample size, and key procedures so reviewers quickly assess scope and potential risks and benefits.
A clear Human Subjects Research Proposal documents ethical safeguards, compliance with federal rules (15 U.S.C. ch. 96; Common Rule), and practical plans for consent, data protection, and risk mitigation. Strong proposals can speed IRB approval and reduce requests for revisions.
Research teams, IRB administrators, and institutional officials commonly prepare or review Human Subjects Research Proposals.
Provide a concise title and abstract summarizing objectives, hypothesis, study design, sample size, and key procedures so reviewers quickly assess scope and potential risks and benefits.
Explain prior research, theoretical justification, and knowledge gaps. Cite relevant literature and explain how the proposed study addresses specific unanswered questions and ethical considerations for participants.
Detail design, eligibility criteria, recruitment strategies, procedures, measurement instruments, sampling, and data analysis plans, including steps to minimize bias and protect participant welfare during all study phases.
Describe consent process, who obtains consent, timing, language, documentation, and procedures for vulnerable populations. Include copies of consent forms and provisions for withdrawal without penalty.
Specify data collection, storage, access controls, de-identification steps, retention schedule, and HIPAA compliance where applicable. Outline encryption, access logging, and plans for secure data sharing or secondary use.
Identify foreseeable risks, probability and severity, mitigation measures, safety monitoring, adverse event reporting, and stopping rules. Include data monitoring committee details if applicable and plans for IRB reporting.
Allow 2–4 weeks for administrative screening.
Full board review may take four to six weeks.
Often completed within two to three weeks.
Most approvals expire annually; renew before expiration.
Report within 24 to 72 hours depending on severity.
| Comparison: Document type and oversight | Human Subjects Research Proposal | Grant Application | Clinical Trial Protocol |
|---|---|---|---|
| Primary audience and submission target | irb/oversight board | funding agency | regulatory agency |
| Required content, focus, and emphasis | ethics and consent | scientific aims and budget | protocol safety ind |
| Typical review timeline and approval bodies | weeks–months | funding cycles | regulatory review |
| Primary legal concerns and compliance focus | consent and privacy | budget and conflicts | safety and ind compliance |
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Varies by vendor | Varies by vendor | Varies by vendor | Varies by vendor |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
| Envelope Cap | No envelope cap | 100 envelopes/user/year | Varies by plan | Varies by plan | Varies by plan |